Search results
Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers
NBC Universal via AOL· 5 days agoPfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for...
AstraZeneca immunotherapy extends survival by two years in rarer type of lung cancer
BioPharma Dive via Yahoo Finance· 3 days ago“This is in contrast to many clinical trials in small cell lung cancer where the benefit may only be...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 2 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
The Biggest Risk Factor for Bladder Cancer Has Nothing to Do With Pee, Diet, or Genes
Verywell Health via Yahoo News· 11 hours agoBladder cancer is common, but one of the biggest risk factors is something you can quit—cigarettes....
Rep. Sheila Jackson Lee reveals she's been diagnosed with pancreatic cancer. Here's what to know...
Yahoo Life· 1 day agoWhy pancreatic cancer is so deadly The subtlety of pancreatic cancer’s symptoms is one of the...
Affimed (AFMD) Soars on Upbeat Follow-Up Data From NSCLC Study
Zacks· 1 day agoThe phase I/IIa AFM24-102 study is evaluating AFM24 in combination with Roche’s (RHHBY Quick...
FDA sets panel review for IceCure's breast cancer treatment By Investing.com
Investing.com· 16 hours agos ProSense® System, a minimally invasive cryoablation technology designed for the treatment of...
...I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer - Puma Biotechnology (NASDAQ:PBYI)
Benzinga· 2 days agoPuma Biotechnology, Inc. PBYI, a biopharmaceutical company, announced the presentation of alisertib for the treatment of patients with advanced osimertinib-resistant epidermal growth factor ...
How to Cope With the Financial Toll of Cancer
Time via Yahoo Finance· 2 days agoEven in the case of an advanced diagnosis, remain hopeful and committed to your treatment plan. “I was diagnosed with stage 4 cancer ...
Affimed's AFM24 With Atezolizumab For EGFR Wild-Type NSCLC Gets FDA Fast Track Status; Stock Up
RTT News· 7 days agoAffimed N.V. (AFMD), a clinical-stage immuno-oncology company, Wednesday announced that it has received Fast Track Designation from the U.S. Food and Drug Administration for ...